Phase 2 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People with a body mass index (BMI) between 18.5 and 45 (a measure of body weight relative to height)
- People who are able to complete study questionnaires tracking their diet and digestive symptoms on their own
- People with a good to fully active level of physical functioning (confirm with trial site what this means for a specific situation)
- People who have been diagnosed with a specific type and stage of skin melanoma (stage IIIB–D that can be surgically removed, or a limited spread of stage IV), or with melanoma affecting the mucous membranes (such as inside the mouth or nose), confirmed by a specialist team
- People who are planned to start a standard treatment course using specific immunotherapy drugs (ipilimumab with or without nivolumab, or nivolumab with or without relatlimab) before surgery
- People whose cancer can be measured using standard imaging criteria (confirm with trial site)
- Women of childbearing potential who have a negative pregnancy test within one week of starting the dietary part of the study
- People who are willing to eat the foods provided as part of the study (with some adjustments for personal food preferences)
- People who are willing to attend scheduled visits, have blood drawn, and provide stool samples
- People who have an existing tumour tissue sample available, or who are already planned to have a tumour biopsy as part of their standard treatment
Who may not be able to join:
- People with a type of eye melanoma called uveal melanoma
- People with a history of inflammatory bowel disease, removal of the entire large bowel, or weight-loss surgery on the stomach or bowel
- People currently taking steroid medication at a dose higher than the equivalent of 10 mg per day of prednisone
- People whose doctor determines the study diet is medically unsuitable for them
- People with major dietary restrictions, including significant food allergies, coeliac disease, or who follow a vegan, ketogenic, or extended fasting diet
- People with insulin-dependent diabetes, or who require a specific type of medication called bile-acid sequestrants
- People who are unable or unwilling to take part in the study procedures
- People who have received intravenous (IV) antibiotics more than once in the past month, or any antibiotic (IV or by mouth) in the past two weeks
- People who regularly take supplements containing prebiotics, fibre, or probiotics and who are unwilling or unable to stop taking them for the study
- People who currently smoke, drink more than 14 alcoholic drinks per week, or use illicit drugs
- People who are currently pregnant, planning to become pregnant, or breastfeeding
- People who have another cancer that requires systemic treatment (other than hormonal therapy)
- People with cognitive impairment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erez Baruch, MD,PHD, M.D. Anderson Cancer Center
Phone: 713-745-5530
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The completion rate, compliance and adherence.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.